Insider Selling: RadNet, Inc. (RDNT) Insider Sells 10,104 Shares of Stock
RadNet, Inc. (NASDAQ:RDNT) insider Jeffrey L. Linden sold 10,104 shares of the company’s stock in a transaction that occurred on Tuesday, August 15th. The stock was sold at an average price of $8.46, for a total transaction of $85,479.84. Following the sale, the insider now directly owns 970,297 shares of the company’s stock, valued at approximately $8,208,712.62. The sale was disclosed in a filing with the SEC, which is available at the SEC website.
RadNet, Inc. (NASDAQ:RDNT) traded down 1.76% during trading on Wednesday, reaching $8.35. 145,324 shares of the company were exchanged. The firm’s 50-day moving average is $7.79 and its 200 day moving average is $6.73. The company has a market capitalization of $394.67 million, a P/E ratio of 43.95 and a beta of 1.01. RadNet, Inc. has a one year low of $5.25 and a one year high of $8.70.
RadNet (NASDAQ:RDNT) last released its quarterly earnings data on Tuesday, August 8th. The medical research company reported $0.11 EPS for the quarter, beating analysts’ consensus estimates of $0.04 by $0.07. RadNet had a net margin of 1.04% and a return on equity of 19.98%. The company had revenue of $230 million during the quarter, compared to analyst estimates of $230.32 million. During the same period last year, the business earned $0.09 earnings per share. RadNet’s revenue was up 5.2% compared to the same quarter last year. On average, analysts anticipate that RadNet, Inc. will post $0.29 EPS for the current fiscal year.
Institutional investors have recently added to or reduced their stakes in the stock. Airain ltd purchased a new position in RadNet during the second quarter worth approximately $100,000. Campbell & CO Investment Adviser LLC purchased a new position in RadNet during the second quarter worth approximately $102,000. National Planning Corp raised its position in RadNet by 9.8% in the second quarter. National Planning Corp now owns 16,796 shares of the medical research company’s stock worth $132,000 after buying an additional 1,500 shares during the period. Prudential Financial Inc. raised its position in RadNet by 29.2% in the first quarter. Prudential Financial Inc. now owns 17,710 shares of the medical research company’s stock worth $104,000 after buying an additional 4,000 shares during the period. Finally, Royce & Associates LP bought a new stake in shares of RadNet during the first quarter valued at about $118,000. Institutional investors own 46.00% of the company’s stock.
Separately, Zacks Investment Research raised shares of RadNet from a “sell” rating to a “hold” rating in a report on Wednesday, May 17th.
RadNet Company Profile
RadNet, Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island.
Receive News & Ratings for RadNet Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet Inc. and related companies with MarketBeat.com's FREE daily email newsletter.